eaa777cd_CER_Inventory___CER_Inventory__Category
[Agency] NIH [Project Title] COMPARATIVE EFFECTIVENESS IN GENOMIC & PERSONALIZED MEDICINE FOR COLON CANCER [Institution] KAISER FOUNDATION RESEARCH INSTITUTE [Amount] $1,999,998 [Summary] Our comprehensive research program in GPM for colorectal cancer will have two main components: 1) secondary data collection through evidence synthesis and cost-effectiveness analysis, and 2) primary data collection through a proof-of-principle study to examine questions about personalized medicine for colorectal cancer. In the proof-of-principle study, we will evaluate the utilization of KRAS and Lynch Syndrome genetic tests within our health systems, and measure the effectiveness of KRAS testing compared with a patient population that does not receive testing. We will also conduct patient and physician interviews to measure psychosocial issues related to KRAS testing, and to help us understand how the genetic test results are used to inform decisions. [Completion/ Closing Date] 09/02/2010 [Link] link [Category] 
Medical treatments, items and services
CER Inventory | CER Inventory
Category